Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 1
2006 2
2007 1
2008 1
2009 1
2010 3
2011 1
2012 5
2013 3
2014 1
2015 2
2016 3
2017 6
2018 7
2019 7
2020 9
2021 9
2022 11
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.
Maggi P, Ricci ED, Martinelli CV, De Socio GV, Squillace N, Molteni C, Masiello A, Orofino G, Menzaghi B, Bellagamba R, Vichi F, Celesia BM, Madeddu G, Pellicanò GF, Carleo MA, Cascio A, Parisini A, Taramasso L, Valsecchi L, Calza L, Rusconi S, Sarchi E, Martini S, Bargiacchi O, Falasca K, Cenderello G, Ferrara S, Di Biagio A, Bonfanti P; CISAI Study Group. Maggi P, et al. Among authors: vichi f. Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612. Viruses. 2023. PMID: 37515298 Free PMC article.
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens.
Maggi P, Ricci ED, Cicalini S, Pellicanò GF, Celesia BM, Vichi F, Cascio A, Sarchi E, Orofino G, Squillace N, Madeddu G, De Socio GV, Bargiacchi O, Molteni C, Masiello A, Saracino A, Menzaghi B, Falasca K, Taramasso L, Di Biagio A, Bonfanti P. Maggi P, et al. Among authors: vichi f. BMC Infect Dis. 2023 Apr 14;23(1):227. doi: 10.1186/s12879-023-08191-2. BMC Infect Dis. 2023. PMID: 37059996 Free PMC article.
Incident diabetes in course of antiretroviral therapy.
Taramasso L, Squillace N, Ricci E, Menzaghi B, Orofino G, Socio GV, Molteni C, Martinelli CV, Madeddu G, Vichi F, Valsecchi L, Celesia BM, Maggi P, Rusconi S, Pellicanò GF, Cascio A, Sarchi E, Gulminetti R, Falasca K, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. Among authors: vichi f. AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14. AIDS. 2023. PMID: 36927963
Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort.
Nicolini LA, Menzaghi B, Ricci E, Pontali E, Cenderello G, Orofino G, Cascio A, Pellicanò GF, Valsecchi L, Molteni C, Vichi F, Bonfanti P, Di Biagio A. Nicolini LA, et al. Among authors: vichi f. Front Med (Lausanne). 2023 Jan 27;10:1086012. doi: 10.3389/fmed.2023.1086012. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36778739 Free PMC article.
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.
Taramasso L, Falletta A, Ricci E, Orofino G, Squillace N, Menzaghi B, De Socio GV, Molteni C, Pellicanò GF, Gulminetti R, Madeddu G, Sarchi E, Vichi F, Celesia BM, Bonfanti P, Di Biagio A; CISAI Study Group. Taramasso L, et al. Among authors: vichi f. Viruses. 2022 Oct 22;14(11):2315. doi: 10.3390/v14112315. Viruses. 2022. PMID: 36366413 Free PMC article.
An explainable model of host genetic interactions linked to COVID-19 severity.
Onoja A, Picchiotti N, Fallerini C, Baldassarri M, Fava F; GEN-COVID Multicenter Study; Colombo F, Chiaromonte F, Renieri A, Furini S, Raimondi F. Onoja A, et al. Commun Biol. 2022 Oct 26;5(1):1133. doi: 10.1038/s42003-022-04073-6. Commun Biol. 2022. PMID: 36289370 Free PMC article.
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity?
Maggi P, De Socio GV, Menzaghi B, Molteni C, Squillace N, Taramasso L, Guastavigna M, Gamboni G, Madeddu G, Vichi F, Cascio A, Sarchi E, Pellicanò G, Martinelli CV, Celesia BM, Valsecchi L, Gulminetti R, Cenderello G, Parisini A, Calza L, Falasca K, Orofino G, Ricci E, Di Biagio A, Bonfanti P. Maggi P, et al. Among authors: vichi f. BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y. BMC Infect Dis. 2022. PMID: 36151508 Free PMC article.
Reversibility of Central Nervous System Adverse Events in Course of Art.
Taramasso L, Orofino G, Ricci E, Menzaghi B, De Socio GV, Squillace N, Madeddu G, Vichi F, Celesia BM, Molteni C, Conti F, Del Puente F, Sarchi E, Angioni G, Cascio A, Grosso C, Parruti G, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. Among authors: vichi f. Viruses. 2022 May 11;14(5):1028. doi: 10.3390/v14051028. Viruses. 2022. PMID: 35632768 Free PMC article.
69 results